Inhibikase Therapeutics, Inc. SEC filings IKT
Inhibikase Therapeutics, Inc. has 368 filings in SEC EDGAR's recent list, going back to Aug 31, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 21, 2026 | Oct 19, 2026 |
| 3 | Initial insider ownership | Oct 21, 2026 | Oct 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 31, 2026 | — |
| 4 | Insider transaction | Jul 31, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 31, 2026 | Jul 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2026 | — |
| 3 | Initial insider ownership | Jul 17, 2026 | Jul 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2026 | — |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 4 | Insider transaction | Feb 24, 2026 | Feb 21, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 21, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| 4 | Insider transaction | Jan 7, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 31, 2025 | — |
| 4 | Insider transaction | Nov 24, 2025 | Nov 21, 2025 |
| 3/A | Filing | Aug 28, 2025 | Feb 21, 2025 |
| 3/A | Filing | Aug 28, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Feb 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 3/A | Primary document | Jul 15, 2025 | Jun 6, 2025 |
| 4/A | Filing | Jul 2, 2025 | Feb 21, 2025 |
| 4/A | Filing | Jul 2, 2025 | Feb 21, 2025 |
| 4/A | Filing | Jul 2, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 14, 2025 |
| 3 | Initial insider ownership | Apr 16, 2025 | Apr 14, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 21, 2025 |
| 3 | Initial insider ownership | Feb 25, 2025 | Feb 21, 2025 |
| 3 | Initial insider ownership | Feb 25, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 3 | Initial insider ownership | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4/A | Filing | Feb 19, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 28, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 28, 2024 | — |
| 3 | Initial insider ownership | Oct 25, 2024 | Oct 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 25, 2024 | — |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 23, 2024 | Oct 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 17, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 17, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 10, 2024 | — |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 4 | Insider transaction | Apr 3, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Apr 1, 2024 |
| 3 | Initial insider ownership | Apr 2, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 5, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Mar 3, 2023 | Mar 1, 2023 |
| 4 | Insider transaction | Mar 3, 2023 | Mar 1, 2023 |
| SC 13D | Ownership over 5% (active) | Feb 24, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2023 | — |
| SC 13D | Ownership over 5% (active) | Jan 31, 2023 | — |
| 4 | Insider transaction | Sep 6, 2022 | Sep 1, 2022 |
| 3 | Initial insider ownership | Sep 6, 2022 | Sep 1, 2022 |
| 4 | Insider transaction | Aug 16, 2022 | Aug 16, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 24, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 24, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 24, 2022 |
| 4 | Insider transaction | Jun 28, 2022 | Jun 24, 2022 |
| 4 | Insider transaction | May 31, 2022 | May 27, 2022 |
| 4 | Insider transaction | May 23, 2022 | May 20, 2022 |
| 4 | Insider transaction | May 23, 2022 | May 19, 2022 |
| 4 | Insider transaction | Mar 21, 2022 | Mar 7, 2022 |
| 4 | Insider transaction | Mar 21, 2022 | Mar 7, 2022 |
| 4 | Insider transaction | Mar 9, 2022 | Mar 7, 2022 |
| 4 | Insider transaction | Mar 9, 2022 | Mar 7, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13D | Ownership over 5% (active) | Jan 11, 2022 | — |
| 4 | Insider transaction | Jan 4, 2022 | Jan 3, 2022 |
| SC 13D | Ownership over 5% (active) | Dec 15, 2021 | — |
| 4 | Insider transaction | Nov 19, 2021 | Nov 17, 2021 |
| 4 | Insider transaction | Aug 19, 2021 | Aug 17, 2021 |
| 4 | Insider transaction | Jun 29, 2021 | Jun 25, 2021 |
| 4 | Insider transaction | Jun 29, 2021 | Jun 25, 2021 |
| 4 | Insider transaction | Jun 29, 2021 | Jun 25, 2021 |
| 4 | Insider transaction | Jun 29, 2021 | Jun 25, 2021 |
| SC 13D | Ownership over 5% (active) | Jun 21, 2021 | — |
| 4 | Insider transaction | May 18, 2021 | May 14, 2021 |
| SC 13G | Ownership over 5% (passive) | Mar 23, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 11, 2021 | — |
| 4 | Insider transaction | Dec 29, 2020 | Dec 22, 2020 |
| 4 | Insider transaction | Dec 29, 2020 | Dec 22, 2020 |
| 4 | Insider transaction | Dec 29, 2020 | Dec 22, 2020 |
| 4 | Insider transaction | Dec 29, 2020 | Dec 22, 2020 |
| 4 | Insider transaction | Dec 29, 2020 | Dec 22, 2020 |
| 4 | Insider transaction | Dec 29, 2020 | Dec 22, 2020 |
| 3 | Initial insider ownership | Dec 22, 2020 | Dec 22, 2020 |
| 3 | Initial insider ownership | Dec 22, 2020 | Dec 22, 2020 |
| 3 | Initial insider ownership | Dec 22, 2020 | Dec 22, 2020 |
| 3 | Initial insider ownership | Dec 22, 2020 | Dec 22, 2020 |
| 3 | Initial insider ownership | Dec 22, 2020 | Dec 22, 2020 |
| 3 | Initial insider ownership | Dec 22, 2020 | Dec 22, 2020 |
| 3 | Initial insider ownership | Dec 22, 2020 | Dec 22, 2020 |
Showing 152 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IKT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1750149
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.